Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1
Author:
Eiichi Ogawa,Norihiro Furusyo,Masayuki Murata,Hiroaki Ikezaki,Takeshi Ihara,Takeo Hayashi,Kazuhiro Toyoda,Hiroaki Taniai,Kyoko Okada,Mosaburo Kainuma,Jun Hayashi
Publication:
Journal of Hepatology
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.